MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Holdings Lifted by Barclays PLC

Barclays PLC lifted its stake in shares of MeiraGTx Holdings plc (NASDAQ:MGTX) by 107.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 147,827 shares of the company’s stock after acquiring an additional 76,437 shares during the quarter. Barclays PLC owned 0.23% of MeiraGTx worth $618,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. BNP Paribas Financial Markets lifted its holdings in shares of MeiraGTx by 142.5% during the third quarter. BNP Paribas Financial Markets now owns 9,319 shares of the company’s stock valued at $39,000 after purchasing an additional 5,476 shares during the last quarter. China Universal Asset Management Co. Ltd. raised its holdings in MeiraGTx by 97.0% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 14,886 shares of the company’s stock worth $62,000 after buying an additional 7,330 shares during the period. The Manufacturers Life Insurance Company lifted its stake in MeiraGTx by 19.0% during the second quarter. The Manufacturers Life Insurance Company now owns 17,763 shares of the company’s stock valued at $75,000 after buying an additional 2,839 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of MeiraGTx in the third quarter worth about $82,000. Finally, Panagora Asset Management Inc. purchased a new position in shares of MeiraGTx in the second quarter worth approximately $97,000. 67.48% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on MGTX shares. Royal Bank of Canada upped their price target on shares of MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research report on Thursday, November 14th. Chardan Capital restated a “buy” rating and issued a $36.00 target price on shares of MeiraGTx in a report on Monday, November 18th.

MeiraGTx Price Performance

Shares of MGTX opened at $6.09 on Thursday. The business’s 50-day moving average is $6.22 and its 200-day moving average is $5.05. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.34 and a quick ratio of 2.34. The company has a market capitalization of $475.95 million, a price-to-earnings ratio of -5.03 and a beta of 1.25. MeiraGTx Holdings plc has a fifty-two week low of $3.85 and a fifty-two week high of $7.57.

MeiraGTx Company Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.